Annual report pursuant to Section 13 and 15(d)

Income Tax - Narrative (Details)

v3.22.4
Income Tax - Narrative (Details) - USD ($)
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Operating Loss Carryforwards [Line Items]      
Research and development credits that do not expire $ 2,700,000    
Deferred tax asset, valuation allowance 287,343,000 $ 208,525,000 $ 95,900,000
Uncertain tax positions 0 0 $ 0
Valuation allowance, deferred tax asset, increase 78,800,000 112,600,000  
Valuation allowance, deferred tax asset, decrease due to to business acquisition   3,300,000  
Meritage Medical Network      
Operating Loss Carryforwards [Line Items]      
Valuation allowance, deferred tax asset, decrease due to to business acquisition   2,600,000  
Higi SH Holdings Inc.      
Operating Loss Carryforwards [Line Items]      
Valuation allowance, deferred tax asset, decrease due to to business acquisition   $ 700,000  
Foreign Tax Authority      
Operating Loss Carryforwards [Line Items]      
Net operating losses 592,500,000    
Domestic Tax Authority      
Operating Loss Carryforwards [Line Items]      
Net operating losses 316,800,000    
Net operating losses, not subject to expiration 295,000,000    
Net operating losses, subject to expiration 21,700,000    
State and Local Jurisdiction      
Operating Loss Carryforwards [Line Items]      
Net operating losses $ 204,000,000